Table 2.

Cross-reactivity of anti-FVIII antibodies



Coagulation time, s

FVIII:C, U/mL


Average

Average
FVIII:C (U/mL)     
Mouse plasma - Ab   40.5   40.35   0.81   0.82  
  40.2    0.83   
Mouse plasma + Ab   66.4   66.80   0.09   0.09  
  67.2    0.09   
FV:C (U/mL)     
Mouse plasma - Ab   11.7   11.75   0.85   0.83  
  11.8    0.81   
Mouse plasma + Ab   11.5   11.50   0.90   0.90  
  11.5    0.90   
FII:C (U/mL)     
Mouse plasma - Ab   19.2   19.25   0.94   0.93  
  19.3    0.92   
Mouse plasma + Ab   19.2   19.00   0.94   0.96  
  18.8    0.98   
FX:C (U/mL)     
Mouse plasma - Ab   11.8   11.90   0.89   0.88  
  12.0    0.86   
Mouse plasma + Ab   11.8   11.65   0.89   0.93  

 
11.5
 

 
0.93
 

 


Coagulation time, s

FVIII:C, U/mL


Average

Average
FVIII:C (U/mL)     
Mouse plasma - Ab   40.5   40.35   0.81   0.82  
  40.2    0.83   
Mouse plasma + Ab   66.4   66.80   0.09   0.09  
  67.2    0.09   
FV:C (U/mL)     
Mouse plasma - Ab   11.7   11.75   0.85   0.83  
  11.8    0.81   
Mouse plasma + Ab   11.5   11.50   0.90   0.90  
  11.5    0.90   
FII:C (U/mL)     
Mouse plasma - Ab   19.2   19.25   0.94   0.93  
  19.3    0.92   
Mouse plasma + Ab   19.2   19.00   0.94   0.96  
  18.8    0.98   
FX:C (U/mL)     
Mouse plasma - Ab   11.8   11.90   0.89   0.88  
  12.0    0.86   
Mouse plasma + Ab   11.8   11.65   0.89   0.93  

 
11.5
 

 
0.93
 

 

Cross-reactivity of anti-FVIII was evaluated against FVIII, FV, FII, and FX. The cross-reactivity of the anti-FVIII antibodies to other relevant coagulation proteins (FV, FX, and FII) was tested in a standard assay and revealed no effects on FV, FII, and FX, while FVIII activity was efficiently neutralized.

Close Modal

or Create an Account

Close Modal
Close Modal